| 000 | 01776 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515060910.0 | ||
| 264 | 0 | _c20070412 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a1744-8328 | ||
| 024 | 7 |
_a10.1586/14737140.7.3.275 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmitt, Anita | |
| 245 | 0 | 0 |
_aDendritic cell vaccines for leukemia patients. _h[electronic resource] |
| 260 |
_bExpert review of anticancer therapy _cMar 2007 |
||
| 300 |
_a275-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntigen Presentation |
| 650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
| 650 | 0 | 4 |
_aCancer Vaccines _xadverse effects |
| 650 | 0 | 4 | _aCell Adhesion |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCells, Cultured _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytokines _xpharmacology |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aImmunotherapy, Active _xadverse effects |
| 650 | 0 | 4 |
_aLeukemia _xtherapy |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xtherapy |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xtherapy |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Immunological |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xcytology |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHus, Iwona | |
| 700 | 1 | _aSchmitt, Michael | |
| 773 | 0 |
_tExpert review of anticancer therapy _gvol. 7 _gno. 3 _gp. 275-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737140.7.3.275 _zAvailable from publisher's website |
| 999 |
_c16895660 _d16895660 |
||